Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
40.5K
-
Shares change
-
0
-
Total reported value, excl. options
-
$56.7K
-
Price
-
$1.40
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2023
1 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2023.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.5K shares
of 170M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), BlackRock Inc. (7.34M shares), VANGUARD GROUP INC (6.01M shares), Hudson Bay Capital Management LP (4.32M shares), BANK OF AMERICA CORP /DE/ (2.36M shares), MILLENNIUM MANAGEMENT LLC (2.22M shares), Point72 Asset Management, L.P. (2.15M shares), GEODE CAPITAL MANAGEMENT, LLC (2.09M shares), STATE STREET CORP (1.91M shares), and TANG CAPITAL MANAGEMENT LLC (1.79M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.